Reduced central alpha power at rest is associated with the risk of alcohol-induced blackout and frequency of non-REM parasomnia episodes in adults. [PDF]
Elliott GM +5 more
europepmc +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
EEG patterns in critically ill comatose patients receiving complementary therapy with aromatic orifice-opening herbs: A preliminary retrospective observational study. [PDF]
Shang WJ +5 more
europepmc +1 more source
Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz +9 more
wiley +1 more source
Beta-Band and Aperiodic Activity Across New and Chronic Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease. [PDF]
Balachandar A +6 more
europepmc +1 more source
Resting-State EEG Power and Aperiodic Activity in Individuals with Mild Cognitive Impairment and Cognitively Healthy Controls. [PDF]
Warren TS +4 more
europepmc +1 more source
Proton-Conducting Sulfonated Periodic Mesoporous Organosilica. [PDF]
Wagner T, Tiemann M.
europepmc +1 more source
Chaotic and dynamic vibration analysis of a time-delayed nonlinear mathieu oscillator via non-perturbative approach. [PDF]
Moatimid GM, Amer TS, Mohamed YM.
europepmc +1 more source

